SGCB and renal fibrosis: Cinaciguat, an sGC activator, improved the glomerular filtration rate and attenuated renal fibrosis in streptozotocin-induced Type 1 diabetic mice with and without endothelial nitric oxide synthase (eNOS) knockout [7].